MYC and prostate carcinoma: This suggests that the enhancement of MYC-driven metabolic and epigenetic reprogramming may be a general mechanism that underlies the influence of dietary fat intake on prostate cancer progression although this hypothesis remains to be tested across prostate cancer molecular subtypes.